Search for:
Search for:
Healthcare Professionals
Publications
News
EspaƱol
Contact
Magazine
Radio
Get Educated
What is MS?
A chronic neurological disorder that affects the central nervous system, comprised of the brain...
More Details
Educational Materials
Common Questions
Lending Library
Symptoms
Treatment Options
Additional Resources
Research
MS Awareness Month
Donate
Get Help
Health & Wellness Program
Get educational materials and referrals, as well as the opportunity to participate in various...
Learn More
Grants & Programs
Awareness Campaigns
Support Groups
Events
Lending Library
Additional Resources
Get Involved
MS Awareness Month
An annual, nationwide campaign with goals to promote an understanding of MS, and to assist those...
Learn More
Advocacy
Buy from Partners
Volunteer
Businesses
MS Research Trials
Outreach
Awareness Campaigns
Host an Event
Events
Test Flyout
lorem ipsum dolor sit lorem ipsum dolor sit lorem ipsum dolor sit lorem ipsum dolor sit lorem...
Learn More
Events Calendar
Health & Wellness
Fundraisers
Support
Web & Teleconferences
MS Education
Host an Event
About Us
Programs & Grants
More Details
Overview
Press Room
Leadership
Financial Statements
Our Mission
Careers at MS Focus
Affiliations
News & Features
Swamp Fitness Exercise
Join us Wednesdays at 9:30 a.m. Eastern, 8:30 a.m. Central, 7:30 a.m. Mountain, 6:30 a.m. Pacific for Exercise...
/Events/MSF-Events/2022/July/Swamp-Fitness-Exercise
Brighter Tomorrow Grant
The Brighter Tomorrow Grant allows MS Focus to makes dreams come true for people with MS across...
/Get-Help/MSF-Programs-Grants/Brighter-Tomorrow-Grant
Shop
Privacy
Terms of Use
Site Map
Medicare patients with MS bear the burden of rising drug prices
August 27, 2019
During the course of a decade, out-of-pocket costs for multiple sclerosis drugs rose more than sevenfold for Medicare Part D beneficiaries, according to a new study. The study’s authors wanted to see how increases in list prices drugs – the starting point before rebates, coupons or insurance kicks in – translated to increases in out-of-pocket spending, and discovered that actual price increases do get passed down to patients, and that can negatively affect access.
Using Medicare claims data from 2006-2016, researchers at the University of Pittsburgh looked at trends in MS drug prices over time. During the time period studied, the annual list prices of these more than quadrupled, ballooning from about $18,000 to nearly $76,000 per patient per year.
Although this trend among list prices is alarming on its own, critics have argued that because some of the cost is canceled out by manufacturer rebates and other kinds of discounts, rising list prices may not be translating into increased spending.
But because Medicare claims provide a detailed cost breakdown, the researchers were able to measure changes in what Medicare Part D beneficiaries actually paid out of pocket for MS drugs, as well as what Medicare itself paid. Not only did they find steep increases in list prices, but also in the ultimate costs to both Medicare and its recipients.
According to the study, Medicare spending increased by more than tenfold from 2006-2016, and the patients themselves saw more than a sevenfold increase in their share of the bill.
The findings were published in
JAMA Neurology
.
MS Focus Lending Library
Books, DVDs, and CDs are available for loan, by mail across the United States.
Learn more